Elevated plasma levels of B-type natriuretic peptide but not C-reactive protein are associated with higher red cell distribution width in patients with coronary artery disease

International Heart Journal

Volumn 50, Issue 3, 2009, Pages 301-312

  Fukuta, Hidekatsu ^a   Ohte, Nobuyuki ^a   Mukai, Seiji ^a   Saeki, Tomoaki ^a   Asada, Kaoru ^a   Wakami, Kazuaki ^a   Kimura, Genjiro ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Erythrocyte; Inflammation; Left ventricular hemodynamics; Neurohormones

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; ERYTHROPOIETIN; FERRITIN; LACTATE DEHYDROGENASE;

AGED; ARTICLE; BODY MASS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ERYTHROCYTE DISTRIBUTION WIDTH; ERYTHROCYTE LEVEL; ERYTHROCYTE PARAMETERS; FEMALE; FERRITIN BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HEART HEMODYNAMICS; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; BLOOD CELL COUNT; C-REACTIVE PROTEIN; CELL SIZE; CORONARY ARTERY DISEASE; ERYTHROCYTE INDICES; ERYTHROPOIETIN; FEMALE; FERRITINS; GLOMERULAR FILTRATION RATE; HEART CATHETERIZATION; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; REFERENCE VALUES; STATISTICS AS TOPIC; SURVIVAL RATE;

EID: 67649992706     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.50.301     Document Type: Article

References (26)

1. Evans TC, Jehle D. The red blood cell distribution width. J Emerg Med 1991; 9 Suppl 1: 71-4. (Review)
2. Felker GM, Allen LA, Pocock SJ, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007; 50: 40-7.
3. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M: for the Cholesterol and Recurrent Events (CARE) Trial Investigators. Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease. Circulation 2008; 117: 163-8.
4. Pierce CN, Larson DF. Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion 2005; 20: 83-90.
5. Kato H, Ishida J, Imagawa S, et al. Enhanced erythropoiesis mediated by activation of the renin-angiotensin system via angiotensin II type 1a receptor. FASEB J 2005; 19: 2023-5.
6. Vlahakos DV, Kosmas EN, Dimopoulou I, et al. Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease. Am J Med 1999; 106: 158-64.
7. Biaggioni I, Robertson D, Krantz S, Jones M, Haile V. The anemia of primary autonomic failure and its reversal with recombinant erythropoietin. Ann Intern Med 1994; 121: 181-6.
8. Sowade O, Sowade B, Gross J, et al. Evaluation of erythropoietic activity on the basis of the red cell and reticulocyte distribution widths during epoetin beta therapy in patients undergoing cardiac surgery. Acta Haematol 1998; 99: 1-7.
9. Ndrepepa G, Kastrati A, Braun S, et al. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease. Am J Med 2006; 119: 355e1-8.
10. Omland T, Richards AM, Wergeland R, Vik-Mo H. B-type natriuretic peptide and long-term survival in patients with stable coronary artery disease. Am J Cardiol 2005; 95: 24-8.
11. Kragelund C, Grønning B, Køber L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005; 352: 666-75.
12. Dai DF, Hwang JJ, Lin JL, et al. Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease. Circ J 2008; 72: 1316-23.
13. George J, Patal S, Wexler D, et al. Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers. Arch Intern Med 2005; 165: 1304-9.
14. Ishikawa C, Tsutamoto T, Fujii M, Sakai H, Tanaka T, Horie M. Prediction of mortality by high-sensitivity C-reactive protein and brain natriuretic peptide in patients with dilated cardiomyopathy. Circ J 2006; 70: 857-63.
15. Tsutamoto T, Sakai H, Nishiyama K, et al. Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure. Circ J 2007; 71: 1873-8.
16. Nishio Y, Sato Y, Taniguchi R, et al. Cardiac troponin T vs other biochemical markers in patients with congestive heart failure. Circ J 2007; 71: 631-5.
17. Goto T, Ohte N, Miyabe H, et al. Usefulness of plasma brain-type natriuretic peptide level to differentiate left ventricular diastolic dysfunction from preserved diastolic function in patients with systolic dysfunction. Am J Cardiol 2005; 95: 1383-5.
18. Yoshida T, Ohte N, Narita H, et al. Lack of inertia force of late systolic aortic flow is a cause of left ventricular isolated diastolic dysfunction in patients with coronary artery disease. J Am Coll Cardiol 2006; 48: 983-91.
19. Fukuta H, Ohte N, Mukai S, Saeki T, Kobayashi K, Kimura G. Anemia is an independent predictor for elevated plasma levels of natriuretic peptides in patients undergoing cardiac catheterization for coronary artery disease. Circ J 2008; 72: 212-7.
20. Weiss JL, Frederiksen JW, Weisfeldt ML. Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest 1976; 58: 751-60.
21. Chapman CB, Baker O, Reynolds J, Bonte FJ. Use of biplane cinefluorography for measurement of ventricular volume. Circulation 1958; 18: 1105-17.
22. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
23. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-67. (Review)
24. Kario K, Matsuo T, Nakao K, Yamaguchi N. The correlation between red cell distribution width and serum erythropoietin titres. Clin Lab Haematol 1991; 13: 222-3.
25. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 2003; 24: 341-56. (Review)
26. Hopkins WE, Chen Z, Fukagawa NK, Hall C, Knot HJ, LeWinter MM. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation 2004; 109: 2872-7.